This document sets forth the Center for Food Safety and Applied Nutrition's (CFSAN's) overall dietary supplement strategy

FDA responds to the recommendations and guidance by the Commission on Dietary Supplement Labels on regulatory and other issues raised by the Dietary Supplement Health and Education Act (DSHEA) of 1994

Letter Regarding Dietary Supplement Health Claim for Antioxidant Vitamins and Certain Cancers

Letter Regarding Dietary Supplement Health Claim for Fiber With Respect to Colorectal Cancer

Compliance Policy Guides (CPG) explain the Food and Drug Administration (FDA) policy on regulatory issues related to the FDA laws or regulations. These include Current Good Manufacturing Practice (CGMP) regulations and application commitments

This page handbook contains valuable information on FDA's requirements and policies for safe production and accurate labeling of cosmetics. The material in it has been carefully selected for use in the production and distribution of cosmetic products.

Letter Regarding Dietary Supplement Health Claim for Folic Acid With Respect to Neural Tube Defects

REGULATORY PROCEDURES MANUAL The purpose of this chapter is to provide an overview of the organizational structure of the offices involved in compliance related functions within the Food and Drug Administration

.... with passage of the Dietary Supplements Health and Education Act of 1994 (DSHEA), Congress amended the FD&C Act to include several provisions that apply only to dietary supplements and dietary ingredients of dietary supplements.

DURK PEARSON AND SANDY SHAW, AMERICAN PREVENTIVE MEDICAL ASSOCIATION AND CITIZENS FOR HEALTH, APPELLANTS v. DONNA E. SHALALA, SECRETARY, UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES